658 related articles for article (PubMed ID: 9156798)
1. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.
Askari FK; Hitomi Y; Mao M; Wilson JM
Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated expression of HUG Br1 in Crigler-Najjar syndrome type I human fibroblasts and correction of the genetic defect in Gunn rat hepatocytes.
Askari F; Hitomi E; Thiney M; Wilson JM
Gene Ther; 1995 May; 2(3):203-8. PubMed ID: 7614251
[TBL] [Abstract][Full Text] [Related]
3. Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors.
Bellodi-Privato M; Aubert D; Pichard V; Myara A; Trivin F; Ferry N
Hepatology; 2005 Aug; 42(2):431-8. PubMed ID: 16025517
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats.
Nguyen TH; Bellodi-Privato M; Aubert D; Pichard V; Myara A; Trono D; Ferry N
Mol Ther; 2005 Nov; 12(5):852-9. PubMed ID: 16140582
[TBL] [Abstract][Full Text] [Related]
5. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
[TBL] [Abstract][Full Text] [Related]
6. [Correction of bilirubin glucuronyl transferase in Gunn rats by gene transfer in the liver using retroviral vectors].
Branchereau S; Ferry N; Myara A; Sato H; Kowai O; Trivin F; Houssin D; Danos O; Heard J
Chirurgie; 1993-1994; 119(10):642-8. PubMed ID: 7729182
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1.
Li Q; Murphree SS; Willer SS; Bolli R; French BA
Hum Gene Ther; 1998 Mar; 9(4):497-505. PubMed ID: 9525311
[TBL] [Abstract][Full Text] [Related]
8. Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat.
Dankó I; Jia Z; Zhang G
Hum Gene Ther; 2004 Dec; 15(12):1279-86. PubMed ID: 15684703
[TBL] [Abstract][Full Text] [Related]
9. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats.
Jia Z; Dankó I
Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256
[TBL] [Abstract][Full Text] [Related]
10. Hepatic conversion of bilirubin monoglucuronide to diglucuronide in uridine diphosphate-glucuronyl transferase-deficient man and rat by bilirubin glucuronoside glucuronosyltransferase.
Chowdhury JR; Jansen PL; Fischberg EB; Daniller A; Arias IM
J Clin Invest; 1978 Jul; 62(1):191-6. PubMed ID: 96142
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo lentivirus transduction and immediate transplantation of uncultured hepatocytes for treating hyperbilirubinemic Gunn rat.
Nguyen TH; Birraux J; Wildhaber B; Myara A; Trivin F; Le Coultre C; Trono D; Chardot C
Transplantation; 2006 Sep; 82(6):794-803. PubMed ID: 17006327
[TBL] [Abstract][Full Text] [Related]
12. In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV.
Montenegro-Miranda PS; Pichard V; Aubert D; Ten Bloemendaal L; Duijst S; de Waart DR; Ferry N; Bosma PJ
Gene Ther; 2014 Feb; 21(2):168-74. PubMed ID: 24285217
[TBL] [Abstract][Full Text] [Related]
13. Gunn rat: a model for inherited deficiency of bilirubin glucuronidation.
Chowdhury JR; Kondapalli R; Chowdhury NR
Adv Vet Sci Comp Med; 1993; 37():149-73. PubMed ID: 8273513
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats.
Seppen J; Bakker C; de Jong B; Kunne C; van den Oever K; Vandenberghe K; de Waart R; Twisk J; Bosma P
Mol Ther; 2006 Jun; 13(6):1085-92. PubMed ID: 16581301
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral vectors that express UGT1A1 in liver and contain miR-142 target sequences normalize hyperbilirubinemia in Gunn rats.
Schmitt F; Remy S; Dariel A; Flageul M; Pichard V; Boni S; Usal C; Myara A; Laplanche S; Anegon I; Labrune P; Podevin G; Ferry N; Nguyen TH
Gastroenterology; 2010 Sep; 139(3):999-1007, 1007.e1-2. PubMed ID: 20546738
[TBL] [Abstract][Full Text] [Related]
16. [Genetic defect of the hyperbilirubinemic Gunn rat, a model for Crigler-Najjar syndrome type I].
Sato H; Aono S; Koiwai O
Nihon Rinsho; 1993 Feb; 51(2):501-6. PubMed ID: 8096554
[TBL] [Abstract][Full Text] [Related]
17. Long-term correction of hyperbilirubinemia in the Gunn rat by repeated intravenous delivery of naked plasmid DNA into muscle.
Jia Z; Dankó I
Mol Ther; 2005 Nov; 12(5):860-6. PubMed ID: 16019265
[TBL] [Abstract][Full Text] [Related]
18. Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer.
Fox IJ; Chowdhury NR; Gupta S; Kondapalli R; Schilsky ML; Stockert RJ; Chowdhury JR
Hepatology; 1995 Mar; 21(3):837-46. PubMed ID: 7875682
[TBL] [Abstract][Full Text] [Related]
19. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector.
Toietta G; Mane VP; Norona WS; Finegold MJ; Ng P; McDonagh AF; Beaudet AL; Lee B
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3930-5. PubMed ID: 15753292
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector.
van der Wegen P; Louwen R; Imam AM; Buijs-Offerman RM; Sinaasappel M; Grosveld F; Scholte BJ
Mol Ther; 2006 Feb; 13(2):374-81. PubMed ID: 16337205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]